U.S. markets open in 8 hours 3 minutes
  • S&P Futures

    4,122.00
    -2.50 (-0.06%)
     
  • Dow Futures

    32,728.00
    -9.00 (-0.03%)
     
  • Nasdaq Futures

    13,016.75
    -14.75 (-0.11%)
     
  • Russell 2000 Futures

    1,913.00
    -1.60 (-0.08%)
     
  • Crude Oil

    90.11
    -0.39 (-0.43%)
     
  • Gold

    1,804.90
    -7.40 (-0.41%)
     
  • Silver

    20.37
    -0.11 (-0.55%)
     
  • EUR/USD

    1.0221
    +0.0003 (+0.03%)
     
  • 10-Yr Bond

    2.7970
    0.0000 (0.00%)
     
  • Vix

    21.77
    +0.48 (+2.25%)
     
  • GBP/USD

    1.2078
    +0.0002 (+0.02%)
     
  • USD/JPY

    134.9900
    -0.1260 (-0.09%)
     
  • BTC-USD

    22,961.47
    -918.66 (-3.85%)
     
  • CMC Crypto 200

    533.14
    -24.21 (-4.34%)
     
  • FTSE 100

    7,488.15
    +5.78 (+0.08%)
     
  • Nikkei 225

    27,794.59
    -205.37 (-0.73%)
     

Inspire Medical Systems, Inc. to Report Second Quarter 2022 Financial Results on August 2, 2022

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc.

MINNEAPOLIS, July 05, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2022 after the close of trading on Tuesday, August 2. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

To access the call, please use the following link: Inspire’s Q2 2022 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.

A simultaneous webcast of the call will be accessible via the Investor Relations page of the Inspire’s website at www.inspiresleep.com. For those not planning to ask a question of management, the Company recommends listening via the webcast.

Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
inspire@lifesciadvisors.com
646-597-6989